Technology | November 01, 2012

Terumo Launches Peripheral Access System

New system facilitates smooth, reliable and precise vascular access


November 1, 2012 — Terumo Interventional Systems announced the nationwide availability of its new Pinnacle Precision Access System. The vascular access system specifically designed for smooth, efficient and reliable peripheral vascular access. It offers the only available tapered introducer needle to minimize vessel trauma, dilate the tissue and gain more precise access in difficult cases, such as those impeded by scar tissue or calcification.

“Terumo’s Pinnacle Precision Access System is one of the most innovative advancements in technology that will help us achieve success in peripheral vascular intervention, specifically where critical limb ischemia (CLI) is present,” said Jihad Mustapha, M.D., FACC, FSCAI, director of endovascular laboratories and director of cardiovascular research at Metro Heart and Vascular, Metro Health Hospital, in Wyoming, Mich. “From the tapered needle to the TIF (total integrated fit) sheath, Terumo provides a seamless transition for vascular access femorally or peripherally.”

One of the system’s most significant advantages is the elimination of procedural steps compared to alternative products. Traditionally, once access is achieved, the site is gradually enlarged to the desired French size by exchanging to a larger wire and sheath. Terumo’s new precision access system eliminates the need for both a micropuncture kit and a standard size introducer sheath. It features proven TIF technology and a new tapered 21 gauge needle that allow for a smaller, straighter and more accurate puncture to significantly reduce vessel entry site trauma and access complications.

The system was designed and developed at Terumo’s manufacturing facility in Elkton, Md. The upgraded facility combines manufacturing and new product development teams in the same geographic location to streamline research and development while maximizing manufacturing efficiencies.

For more information: www.terumois.com


Related Content

News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
News | Peripheral Artery Disease (PAD)

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
News | Peripheral Artery Disease (PAD)

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
News | Peripheral Artery Disease (PAD)

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
News | Peripheral Artery Disease (PAD)

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
Subscribe Now